Genagon Therapeutics's drug development is based on discoveries of unstudied proteins and their life cycles in innate immune cells.
Member count: 11-50
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | Beijer Ven... | beijervent... |
| - | Almi Inves... | almi.se |